The Current Ratio as of November 2024 (TTM) for AcelRx Pharmaceuticals, Inc. (ACRX) is 4.04

According to AcelRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.04. This represents a change of 65.60% compared to the average of 2.44 of the last 4 quarters.

AcelRx Pharmaceuticals, Inc. (ACRX) Historical Current Ratio (quarterly & annually)

How has ACRX Current Ratio performed in the past?

The mean historical Current Ratio of AcelRx Pharmaceuticals, Inc. over the last ten years is 5.03. The current 4.04 Current Ratio has changed 7.92% with respect to the historical average. Over the past ten years (40 quarters), ACRX's Current Ratio was at its highest in in the March 2014 quarter at 20.39. The Current Ratio was at its lowest in in the September 2022 quarter at 1.57.

AcelRx Pharmaceuticals, Inc. (ACRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AcelRx Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AcelRx Pharmaceuticals, Inc. (ACRX) Average Current Ratio

How has ACRX Current Ratio performed in the past?

The current Current Ratio of AcelRx Pharmaceuticals, Inc. (ACRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

AcelRx Pharmaceuticals, Inc. (ACRX) Current Ratio vs. Peers

How is ACRX’s Current Ratio compared to its peers?

AcelRx Pharmaceuticals, Inc.’s Current Ratio is greater than Mallinckrodt plc (2.74), greater than Lifecore Biomedical, Inc. (1.83), greater than Lucy Scientific Discovery Inc. (0.38), greater than Alimera Sciences, Inc. (2.79), greater than Adamis Pharmaceuticals Corporation (0.58), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Catalent, Inc. (2.51), greater than Tilray Brands, Inc. (2.47), less than Aquestive Therapeutics, Inc. (6.37), greater than Evoke Pharma, Inc. (1.44), less than Guardion Health Sciences, Inc. (16.67), greater than Organogenesis Holdings Inc. (3.09), greater than Agile Therapeutics, Inc. (0.55), greater than Assertio Holdings, Inc. (2.01), greater than Amneal Pharmaceuticals, Inc. (1.38),

Build a custom stock screener for AcelRx Pharmaceuticals, Inc. (ACRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AcelRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AcelRx Pharmaceuticals, Inc. (ACRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AcelRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.